Kantarjian, H. M., Zugmaier, G., Brüggemann, M., Wood, B. L., Horst, H. A., Zeng, Y., & Martinelli, G. (2021). Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG.
Cita Chicago Style (17a ed.)Kantarjian, Hagop M., Gerhard Zugmaier, Monika Brüggemann, Brent L. Wood, Heinz A. Horst, Yi Zeng, y Giovanni Martinelli. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG, 2021.
Cita MLA (8a ed.)Kantarjian, Hagop M., et al. Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. MDPI AG, 2021.